Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
46.3M
-
Shares change
-
+85.4K
-
Total reported value, excl. options
-
$667M
-
Value change
-
-$2.17M
-
Put/Call ratio
-
0.68
-
Number of buys
-
42
-
Number of sells
-
-32
-
Price
-
$14.40
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q3 2018
97 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q3 2018.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.3M shares
.
Largest 10 shareholders include NEA Management Company, LLC (9.09M shares), WELLINGTON MANAGEMENT GROUP LLP (5.67M shares), OppenheimerFunds, Inc. (4.42M shares), FMR LLC (3.8M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.44M shares), BlackRock Inc. (2.85M shares), Redmile Group, LLC (2.05M shares), FRANKLIN RESOURCES INC (2.02M shares), STATE STREET CORP (1.76M shares), and Vanguard Group Inc (1.69M shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.